All stock lists
Unlock the score
BlossomHill Therapeutics, Inc. (NASDAQ:BLSM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
15.57+0.94 (+6.43%)
Market cap
$453M
Insider Score
Analyst consensus
Listed since
Aug 7, 2026
Website
Insider Score
/ 100
BLSM Insider Score
BlossomHill Therapeutics, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
BLSM Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BLSM patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BLSM from public contracts
Source: USAspending.gov
Recently reported changes in BLSM holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing BLSM, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for BLSM. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.